849
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Beneficial and adverse side effects of vaccination: perception in developing countries

&
Pages 785-787 | Published online: 09 Jan 2014

References

  • Baxby D. Edward Jenner’s inquiry: a bicentenary analysis. Vaccine 17, 301–307 (1999).
  • Author correspondance. Pearson K. Br. Med. J.1667, 1243–1246 (1904); Wright AE. Br. Med. J.1667, Wright AE. 1727 1489–1491 (1904).
  • Varrichio F. Vaccine adverse event reporting: the importance of follow-up. Expert Rev. Vaccines 4(4), 445–448 (2005).
  • Mamidipudi TK, Sundeep SS. Could administration of Bacille Calmette-Guérin vaccination at birth protect from the development of asthma and allergic diseases in the western world? Has this question been adequately investigated? Pediatr. Allergy Immunol. 13(3), 172–176 (2002).
  • Ota MOC, Vekemans J, Schlegel-Haueter SE et al. Influence of Mycobacterium bovis Bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J. Immunol. 168, 918–925 (2002).
  • Campion EW. Suspicions about the safety of vaccines. N. Engl. J. Med. 347(19), 1474–1475 (2002).
  • Shaw FE, Graham DJ, Guess HA et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Am. J. Epidemiol.127(2), 337–352 (1988).
  • Confavreux C, Suissa S, Saddier P, Boydes V, Vukusic S; Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. N. Engl. J. Med. 344, 319–326, (2001).
  • Ascherio A, Shumin MZ, Hernan MA et al. Hepatitis B vaccination and the risk of multiple sclerosis. N. Engl. J. Med. 344, 327–332 (2001).
  • Madsen KM, Hviid A, Vesterggard M et al. A population-based study of measles, mumps and rubella vaccination and autism. N. Engl. J. Med. 347, 1477–1482 (2002).
  • DeStefano F, Thompson WW. MMR vaccine and autism: an update of the scientific evidence. Expert Rev. Vaccines. 3(1), 19–22 (2004).
  • Nuwaha F, Mulindwa G, Kabwongyera E, Barenzi J. Causes of low attendace at National Immunization Days for polio eradication in Bushenyi District, Uganda. Trop. Med. Int. Health 5(5), 364–369 (2000).
  • Samuelsen H. Infusions of health: the popularity of vaccinations among Bissa in Burkina Faso. Anthr. Med. 8(2–3), 163–175 (2001).
  • Pincock S. Poliovirus spreads beyond Nigeria after vaccine uptake drops. BMJ 328, 310 (2004).
  • Cooper WO, Boyce TG, Wright PF, Griffin MR. Do childhood vaccines have non-specific effects on mortality? Bull. World Health Organ. 81(11), 821–826 (2003).
  • Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 321, 1435–9 (2000).
  • Vaugelade J, Pinchinat S, Guiella G et al. Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso. BMJ 329(7478), 1309–1313 (2004).
  • Breiman RF, Streatfield PK, Phelan M et al. Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data. Lancet 364(9452), 2204–2211 (2004).
  • Lehmann D, Vail J, Firth MJ et al. Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua-New-Guinea. Int. J. Epidemiol. 34, 138–148 (2005).
  • Moulton H, Rahmathullah L, Hasey NA et al. Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population. TMIH 10(10), 1–9 (2005).
  • Elguero E, Simondon KB, Vaugelade J, Marra A, Simondon F. Non-specific effects of vaccination on child survival? A prospective study in Senegal. Trop. Med. Int. Health 10(10), 956–960 (2005).
  • Farrington CP. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine 22, 2064–2070 (2004).
  • Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research design. N. Engl. J. Med. 342(25), 1887–1892 (2000).
  • Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinicals trial. BMJ 317, 1185–1190 (1998).
  • Comstock GW. Vaccine evaluation by case-control or prospective studies. Am. J. Epidemiol. 131(2), 205–208 (1990).
  • Schneeweiss S. Methods in pharmacoepidemiology: an invited series. Pharmacoepidemiol. Drug Safety. 14, 453–454 (2005).
  • Benn CS, Balé C, Sommerfelt H, Friis H, Aaby P. Hypothesis: vitamin A supplementation and childhood mortality: amplification of the non-specific effects of vaccines. Commentary by Stephensen CB. Int. J. Epidemiol.32, 822–829 (2003).
  • Streefland P, Chowdhury AMR, Ramos-Jimenez P. Patterns of vaccination acceptance. Soc. Sci. Med. 49, 1705–1716 (1999).
  • Dean K. The role of methods in maintening orthodox beliefs in health research. Soc. Sci. Med. 58, 675–685 (2004).
  • Gangarosa EJ, Galazka AM, Wolfe CR et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 351, 356–361 (1998).
  • Jansen VAA, Stollenwerk N, Jensen HJ et al. Measles outbreaks in a population with declining vaccine uptake. Science 301, 804 (2003).
  • Sniadack DH, Moscoso B, Aguilar R, Heath J, Bellini W, Chiu MC. Measles epidemiology and outbreak response immunization in a rural community in Peru. Bull. World Health Organ.77(7), 545–552 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.